Abstract

Summary

Melanopsin-containing retinal ganglion cells decline with age and in neurodegenerative diseases such as Parkinson's, impairing circadian photoentrainment and contributing to sleep and circadian disorders. For lighting designers and healthcare providers, this underscores the need for higher-intensity or melanopically optimized lighting in elderly and neurologically impaired populations to compensate for reduced photoreceptor sensitivity.
Abstract

Key Findings

  • Average density of melanopsin-positive retinal ganglion cells declines after age 70, accompanied by age-dependent atrophy of dendritic arborization.
  • mRGC number and plexus complexity are specifically impaired in Parkinson's disease patients, potentially explaining sleep and circadian rhythm disorders associated with this condition.
  • Progressive deterioration and loss of mRGCs in both inner and outer retinal diseases positively correlates with progressive alterations in circadian rhythms.
  • The review concludes that preserving eye health—even in the absence of functional vision—is critical for maintaining mRGC integrity and circadian health.
Categories

Categories

The Science of Light: Reviews melanopsin-containing retinal ganglion cell (mRGC) biology, function in circadian photoentrainment and pupillary light reflex, and their deterioration with age and disease.
Dementia & Elder Care: Covers mRGC loss in aging and neurodegenerative diseases including Parkinson's, with direct implications for circadian rhythm disorders in elderly populations.
Eye Health & Vision: Examines retinal maintenance and progressive mRGC deterioration in inner and outer retinal diseases, linking photoreceptor loss to circadian dysfunction.
Authors

Author(s)

KD Wilcots
Publication Date

Publication Year

2022
View more publications